Feature | Angiography | Dave Fornell, Editor
June 6, 2018 — Here is a checklist of dose-sparing practices for angiographic X-ray imaging used in the cath lab. This ...
June 06, 2018
Technology | PET-CT
June 5, 2018 — The U.S. Food and Drug Administration (FDA) has cleared the Biograph Vision, a new positron emission ...
June 05, 2018
News | EP Lab
June 5, 2018 — Philips Healthcare has signed an agreement to acquire EPD Solutions, a provider of image-guidance in ...
June 05, 2018Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature | Information Technology
June 5, 2018 — The future of cardiovascular care will be transformed by advances in artificial intelligence, digital ...
June 05, 2018
Feature | Ventricular Assist Devices (VAD)
June 4, 2018 — The U.S. Food and Drug Administration said Medtronic initiated a Class 1 recall all 204,017 of its ...
June 04, 2018
Feature | Radiation Dose Management | Dave Fornell, Editor
A new consensus document on how to mitigate radiation exposure in cardiac imaging for both patients and staff was issued ...
June 01, 2018Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News | Heart Valve Technology
June 1, 2018 – Use of the Abbott Portico transcatheter aortic valve replacement (TAVR) therapy was associated with ...
June 01, 2018
The U.S. Food and Drug Administration (FDA) is issuing a proposed order to reclassify certain radiological medical image analyzers, or computer-aided detection (CAD) devices, from class III to class II devices. This includes CAD devices for mammography breast cancer, ultrasound breast lesions and radiograph lung nodules.
June 01, 2018
Feature | Dave Fornell, Editor
June 1, 2018 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...
June 01, 2018Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Stents Drug Eluting
Late-breaking trial results presented at the EuroPCR Congress, May 21-24 in Paris, France, found the Optimax titanium-nitride-oxide (TiNO)-coated Optimax stent was superior to the Synergy everolimus-eluting stent (EES) in acute coronary syndrome (ACS) patients. Results were presented by Pasi Karjalainen, M.D., Heart Center, Satakunta Central Hospital, Pori, Finland.
May 31, 2018
Feature | Radiation Dose Management | Dave Fornell, Editor
May 31, 2018 — Here is a checklist of dose-sparing practices for nuclear cardiology that was included in a new 2018 ...
May 31, 2018
News | Stents Drug Eluting
Two-year outcome data from the BIO-RESORT randomized controlled trial were presented in a late-breaking clinical trials session at EuroPCR 2018, May 21-24 in Paris, France.
May 31, 2018Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Feature | EuroPCR
Here are the late-breaking trials and other key study presentations from the 2018 EuroPCR conference. This is the annual ...
May 31, 2018
Feature | Intra-Aortic Balloon Pumps (IABP)
May 31, 2018 — The results from the Survival Improvement in Extensive Myocardial Infarction with PERsistent Ischemia ...
May 31, 2018
Feature | Renal Denervation
May 30, 2018 — Despite the best efforts of clinicians to manage hypertension, it continues to increase and is now ...
May 30, 2018© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now